Thomas Spencer, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Avekshan
    Topic:
    Consultation (MGH Advisor)
    Date added:
    01/25/2022
    Date updated:
    03/09/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    The FDA; Department of Defense
    Topic:
    Research Support (MGH PI)
    Date added:
    01/25/2022
    Date updated:
    03/09/2024
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    ADHD Scales Royalty Licensing
    Topic:
    Royalties (MGH Corporate Sponsored)
    Date added:
    01/25/2022
    Date updated:
    03/09/2024
  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    US patent (#61/233,686)
    Topic:
    Non-Stimulant Treatment for ADHD (no license fees)
    Date added:
    01/25/2022
    Date updated:
    03/09/2024
  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    US patent (#61/233,686)
    Topic:
    Stimulant Abuse Prevention (no license fees)
    Date added:
    01/25/2022
    Date updated:
    03/09/2024
Return to Child & Adolescent Psychopharmacology 2022